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Alcohol Research Group, 6001 Shellmound St, Suite 450, Emeryville, CA 94608, USA
d
School of Nursing & Department of Psychiatry, Columbia University, 630 West 168th Street, Mail Box Code 6, New York, NY 10032, USA
b
c
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Background: Differences in alcohol, tobacco, and other drug (ATOD) use by sexual identity vary across samples of
women recruited using different sampling methods. We used propensity score (PS) weighting methods to address
two methodological questions: (1) Do disparities between sexual minority women (SMW) and heterosexual
women persist when differences in risk and protective factors are similarly distributed between groups, and (2)
Does accounting for SMW-specific resiliency factors impact differences between non-probability samples of
SMW? Methods: Four samples included SMW from a longitudinal study with a nonprobability sample (n = 373),
a national general population panel sample (n = 373), and a national LGBTQ-specific panel sample (n = 311), as
well as a national probability sample of heterosexual women (n = 446). Between-groups analyses using doublerobust PS weighted models estimated differences in ATOD use under hypothetical conditions in which samples
have similar risk and protective factors. Results: After PS weighting, imbalance in confounders between SMW
and heterosexual samples was substantially reduced, but not eliminated. In double-robust PS weighted models,
SMW samples consistently had significantly greater odds of drug use than heterosexuals, with odds from 8.8 to
5.6 times greater for frequent marijuana use and 4.8–3.2 greater for other drug use. Few differences between
SMW samples in ATOD outcomes or other variables remained after PS weighting. Conclusion: Relative to het
erosexual women, disparities in marijuana and other drug use among SMW are evident regardless of sampling
strategy. The results provide some reassurance about the validity of large nonprobability samples, which remain
an important recruitment strategy in research with SMW.

1. Introduction
Recognition of the need to improve the quantity and quality of
research studies on the health of sexual and gender minority (SGM)
populations has grown substantially over the past 20–25 years (Institute
of Medicine, 2011; National Academies of Sciences, 2020; Solarz, 1999).
In addition, there have been calls for research to improve understanding
of the disparities in health among SGM subpopulations that have his
torically been under-represented in research, such as sexual minority
women (SMW, e.g., lesbian and bisexual women) (Coulter et al., 2014;
Hughes et al., 2020; Institute of Medicine, 2011; Solarz, 1999). Dis
parities in heavy alcohol use, tobacco use, and other drug use are

particularly pronounced among SMW (Blosnich et al., 2013; Hughes
et al., 2020; Johnson et al., 2016; Lee et al., 2009; Wheldon et al., 2018),
and research suggests that these disparities have persisted over time
despite social and policy changes supportive of SGM populations
(Drabble et al., 2020; McCabe et al., 2021). Research on factors that may
drive health disparities is important for informing the development of
interventions to reduce those disparities (Blosnich et al., 2013; Hughes
et al., 2020; Kidd et al., 2022). However, methodological challenges,
particularly in sampling, have impeded progress in research on sexual
orientation-related health disparities, including disparities in alcohol,
tobacco, and other drug (ATOD) use.
One important methodological challenge is a gap in understanding
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how estimates of adverse health outcomes differ among SMW recruited
using different nonprobability sampling strategies. This is important
because nonprobability sampling continues to have an important role in
reaching SMW in health research. Insights about how different sampling
strategies may yield similar or different results are crucial to interpreting
study findings and assessing the utility of different sampling strategies in
research on specific health outcomes. The current study addresses this
critical methodological challenge by examining similarities and differ
ences in estimates of ATOD use among SMW recruited using different
nonprobability sampling strategies.

et al., 2020). For example, one methodological study comparing esti
mates of substance use in samples of SMW recruited using probability
and nonprobability sampling methods with a probability sample of
heterosexual women found higher rates of substance use in both samples
of SMW. However, rates of tobacco use were higher and rates of other
drug use were lower among SMW in the probability sample than among
SMW in the nonprobability sample (Drabble et al., 2018). A possible
reason for these differences is that sexual minority respondents with
higher economic status, greater educational attainment, and greater
connectedness to LGBTQ communities may be overrepresented in non
probability samples (Boehmer et al., 2008; Bowen et al., 2007; Drabble
et al., 2018; Krueger et al., 2020; Salway et al., 2019).
Use of large online panel samples (volunteer respondents who agree
to receive incentivized invitations to complete surveys) appear to be a
promising strategy for researchers interested in conducting national
surveys with hard-to-reach populations (Boyle et al., 2017). However,
there is a paucity of methodological research on the characteristics of
online web-panel samples relative to probability samples (Boyle et al.,
2017) or nonprobability samples of SMW recruited using other strate
gies (Canan et al., 2021). To our knowledge, no studies to date have
compared substance use outcomes among SMW recruited through on
line panel samples with outcomes among heterosexual women from a
probability sample and with outcomes in other large well-designed
nonprobability samples of SMW.

1.1. Methodological challenges
Early research on ATOD use among SMW relied on convenience
samples, such as bar patrons or clinical samples, which raised concerns
about generalizability and overestimates of problems (Hughes, 2011).
Over the last two decades, research with SMW has advanced through
studies with more representative sampling designs. A growing number
of studies using probability samples have included sexual orientation
measures, allowing for greater generalizability and more appropriate
comparisons between heterosexual and sexual minority samples (Owens
et al., 2020). Although inclusion of sexual orientation measures in
health studies using probability samples is crucial for health surveil
lance, important challenges concerning probability samples in SGM
research remain. First, the low base rate of sexual minority respondents
in probability samples often limits comparisons across subgroups of
sexual minorities (Meyer et al., 2020; Meyer and Wilson, 2009). Second,
reaching small or hidden populations using probability sampling
methods is often cost prohibitive (National Academies of Sciences, En
gineering, and Medicine, 2018). In addition, probability studies of the
general population rarely include sexual minority-specific measures that
contribute to sexual orientation-related health disparities, such as the
extent to which and to whom participants have disclosed their sexual
orientation (Hatzenbuehler and Pachankis, 2021).
Because of these challenges, survey research using new methods and
strong nonprobability designs is important for understanding factors
that underlie sexual orientation-related health disparities (Hatzen
buehler and Pachankis, 2021). Examples of sampling strategies in survey
research with SMW include online and social media sampling, as well as
outreach through multiple sources such as lesbian, gay, bisexual,
transsexual, and queer (LGBTQ) in-person venues, community organi
zations, social networks, and LGBTQ media (National Academies of
Sciences, 2018). Nonprobability studies of SGM individuals are most
commonly designed to obtain large enough samples to enable exami
nation of within-group differences (e.g., comparisons across sexual
identities or by race/ethnicity), and to include important sexual
minority-specific measures (Institute of Medicine, 2011; Meyer and
Wilson, 2009).
Alternative strategies, such as respondent-driven sampling (RDS),
have been successfully applied in public health research to collect data
from hard-to-reach populations, such as men who have sex with men
and injection drug users (National Academies of Sciences, 2018).
However, recent methodological studies have found that RDS sampling
with SMW fails to generate robust chains of referrals, which are neces
sary to approximate a probability sample (Martin et al., 2015; Michaels
et al., 2019; Middleton et al., 2022). Recently, pre-established national
web panels have emerged as a potential strategy for reaching large
samples of sexual minority respondents, while minimizing potential bias
associated with volunteer participants from LGBTQ-specific community
venues and networks (Anderssen and Malterud, 2017).
Methodological studies of sexual minority health using different
sampling strategies to estimate outcomes are important to guide the
interpretation of findings from studies using nonprobability designs and
to identify ways to improve the quality of samples. In general, different
sampling strategies appear to yield similar results, but effect sizes may
differ based on the sampling strategy used (Hottes et al., 2016; Krueger

1.2. Risk factors associated with behavioral health outcomes in SMW
Risk and protective factors for ATOD use are not equally distributed
across women of differing sexual identities. Several factors linked with
greater risk for substance use among women appear to impact SMW
disproportionately relative to heterosexual women, and some SMW
relative to others (e.g., bisexual women are at higher risk than lesbian
women). These risk factors include history of victimization, such as
childhood sexual and physical abuse (Drabble et al., 2013; Hughes et al.,
2014; Hughes, McCabe et al., 2010; Hughes, Szalacha et al., 2010;
McCabe et al., 2022; Wilsnack et al., 2008); early onset of alcohol, to
bacco, or marijuana use (Hughes et al., 2007; Talley et al., 2019; Wils
nack et al., 2008); and coping motivations for alcohol or drug use (Lewis
et al., 2017; Talley et al., 2012). Demographic factors that often protect
against substance use among women also vary by sexual identity. For
example, although family composition is changing rapidly in the context
of social and political changes (e.g., legalization of same-sex marriage),
SMW are less likely to be in committed/married relationships than
heterosexual women (Drabble et al., 2020; Hughes et al., 2020), and
marital/relationship status may be less consistently protective against
substance use, such as hazardous drinking and marijuana use, among
SMW relative to heterosexual women (Trocki et al., 2020; Veldhuis
et al., 2020). In addition, although some research has found a lower risk
of substance use (e.g., alcohol use disorders) among Black, Latinx, or
Asian women than among White women, studies with SMW have found
no differences, or even greater use, among racially minoritized SMW
than in White SMW (Hasin and Grant, 2015; Hughes et al., 2020; Mulia
and Bensley, 2020).
Sexual minority-specific factors also influence ATOD use. Social
stress frameworks (Thoits, 2010) and minority stress theory (Meyer,
2003, 2013) suggest that differential exposure to stressors is an impor
tant contributor to health disparities among sexual minorities. For
example, stress related to the disclosure of minority sexual identi
ty—and reactions to disclosure—influence substance use and other
health outcomes (Baiocco et al., 2010; Blosnich et al., 2013; Everett
et al., 2021; Johnson et al., 2013; Pachankis et al., 2015, 2020; Persson
et al., 2015).
1.3. The current study
This study addressed two methodological questions: (1) do
2
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disparities between SMW and heterosexual women persist when differ
ences in risk and protective factors are similarly distributed between
groups, and (2) does accounting for SMW-specific resiliency factors
impact differences between non-probability samples of SMW? To
address the first question, we estimated differences in ATOD use under
hypothetical conditions in which SMW and their heterosexual counter
parts have similar risk and protective factors. We conducted betweengroups analyses using propensity score weighted (PSW) models to ac
count progressively for key individual-level demographics and psycho
logical risk factors, creating analytically comparable SMW samples for
comparisons of ATOD use relative to heterosexual women. To address
the second question, we used PSW to conduct comparative analyses
within SMW to assess SMW-specific resiliency factors that may buffer
the effects of risk factors on ATOD use, comparing outcomes among
samples recruited using different sampling strategies.

invited to participate in a supplemental telephone survey. Some of the
questions in this survey were subsequently used in our surveys with the
SMW panel samples, and with all samples we included many of the same
ATOD questions as in in the CHLEW study.
2.1.4. Final analytic sample
Our analyses included women who identified as heterosexual in the
NAS sample and as bisexual or lesbian in the three SMW samples. To
maximize comparability of the four samples and to avoid extreme
weights, we excluded women older than 70 (who were overrepresented
in the NAS sample) and women who did not identify as White, Black/
African American, or Hispanic/Latina (who were not well-represented
in the NAS sample due to the sampling design). Thus, we included
1529 women (446 from NAS, 399 from CHLEW, 373 from the general
population panel sample of SMW, and 311 from the LGBT panel sample)
in our analyses. Table 1 provides unweighted demographics for each
sample, along with PS-weighted demographics (methods described
below).

2. Methods
2.1. Datasets and analytic sample

2.2. Measures

The current study was part of a larger project on ATOD use among
SMW which included three SMW samples (SMW from a large non
probability sample, SMW from a national general population web panel
sample, and SMW from a national LGBTQ-specific web panel sample)
and a fourth comparison probability sample of heterosexual women
(each are described in detail below). Human subject protection and
oversight was provided by the Institutional Review Boards of the
engaged institutions.

2.2.1. Alcohol use and problems
We constructed two dichotomous alcohol-related outcomes. One
assessed whether participants had consumed four or more drinks in the
same day on one or more occasions in the past year (any occasions of 4 +
drinking vs. none). The other assessed alcohol use disorder (American
Psychiatric Association, 2013) using affirmative responses to two or
more or of 11 symptoms in the past year (vs. none or one), corre
sponding to at least mild alcohol use disorder.

2.1.1. Chicago Health & Life Experiences of Women (CHLEW) Study
The Chicago Health and Life Experiences of Women (CHLEW) study
is a 21-year longitudinal, community-based study of risk and protective
factors associated with alcohol use and alcohol-related problems among
an age and racially/ethnically diverse sample of lesbian and bisexual
women. The CHLEW includes multiple sexual minority specific mea
sures, and has contributed to understanding differences in harmful
alcohol use among SMW based on sexual identity, age, race/ethnicity
and other factors (Hughes et al., 2021). The current study used data from
SMW interviewed in Wave 4 (2017–2019). See Hughes et al. (2021) for
in-depth information about the CHLEW study.

2.2.2. Tobacco use
Tobacco use was assessed using questions about whether and how
often participants had tobacco in the past 12 months. Past-year tobacco
use was coded as any tobacco use (vs. no use).
2.2.3. Other drug use
A dichotomous measure of frequent marijuana use was constructed
based on a question about how often the participant had used marijuana,
hash, pot, THC or “weed” in the past 12 months. Frequent past-year use
was defined as using once per week or more often (vs. less than once per
week or not at all). Any past-year illicit drug use, other than marijuana
(i.e., stimulants, cocaine/crack, club drugs, and non-medical use of
prescription drugs), was also coded dichotomously (any use of one or
more illicit drugs vs. no use).

2.1.2. Panel samples
SMW participants also were recruited from two national online
panels: a general population panel sample (n = 333) and a targeted
panel sample of LGBTQ adults (n = 399). Eligibility requirements for
participation included being 18 or older; identification as lesbian,
bisexual, or queer; residence in the United States, and identification as
female at the time of the screening. Because the aims of the larger study
on ATOD use among SMW relied upon having adequate sample sizes for
comparisons by race/ethnicity with specific subgroups, recruitment
strategies oversampled SMW who identified as Black/African American
or Latina/Latinx. Specifically, we randomly selected a sample that was
one third Black/African American, one third Latina/Latinx; and onethird unspecified race/ethnicity (of which the majority were nonHispanic White). Data were collected over the summer and fall of 2019.

2.2.4. Demographics and other risk/protective factors
Sexual identity was constructed as a three-category variable: het
erosexual, lesbian, bisexual. Participants from the general population
panel sample, CHLEW, and probability sample were classified based on a
question that asked: “Recognizing that sexual identity is only party of
your identity, which of the following statements best describes your
sexual orientation?” The LGBTQ-specific panel allowed participants to
select multiple categories of sexual identity and these women were
classified based on their identification as lesbian, bisexual, or other nonmonosexual identity (e.g., women who selected pansexual were classi
fied as bisexual) for comparability. The comparison sample from the
national probability survey was selected based on their endorsement of a
heterosexual identity; the few participants who selected “mostly het
erosexual” were excluded from the current analysis. Other de
mographics included age (in years), race/ethnicity (non-Hispanic White
vs. Black/African American or Latinx/Hispanic), employment status
(employed full- or part-time vs. unemployed), educational status
(attended at least some college or more vs. attained high-school diploma
or less), relationship status (married/cohabitating and separated/
divorced/widowed vs. never married), and parenting status (any child
under age 18 in the home vs. none).

2.1.3. Heterosexual comparison sample: National Alcohol Survey
The sample of heterosexual women (n = 623) consisted of partici
pants from the 2014–15 National Alcohol Survey (NAS) who agreed to
be recontacted for future research. The NAS involved computer-assisted
telephone interviews conducted with English- or Spanish-speaking U.S.
adults aged 18 and older. The NAS used a dual-frame sampling design
that included randomly selected households with landlines and cellular
phone users, and it also oversampled Black/African American and His
panic/Latinx respondents (Karriker-Jaffe et al., 2017). In 2016, a
random sample of 1961 NAS female participants was recontacted and
3
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Table 1
Comparing samples of sexual minority women with heterosexual women: Covariate balance before and after propensity score weighted analyses.
Comparison group

Unweighted

After full PS weighting

Hetero-sexual
women in NAS

SMW Longitudinal
Chicago sample
(CHLEW)

Non-Hispanic White

58.2%

48.0%

Black/African American

28.8%

37.8%

25.5%

Hispanic/Latinx

13.0%

14.2%

35.0%

*

31.0%

Age (mean, SD)

47.13 (12.5)

*

31.54 (10.20)

*

Minor children in home

50.11
(13.65)
36.3%

11.4%

*

41.5%

39.05
(13.52)
12.6%

Employed

52.5%

75.9%

*

74.3%

*

81.0%

College education

74.0%

86.8%

*

70.7%

Married/partnered

53.9%

30.5%

*

27.4%

*

29.0%

Living with someone as
couple
Separated, divorced or
widowed
Single/never married

12.8%

34.5%

*

46.6%

*

37.1%

14.8%

4.6%

*

5.7%

*

2.3%

Substance use to cope
(mean, SD)
Childhood physical or
sexual abuse
Early onset drinking

1.14
(.37)
28.8%

1.45 (0.75)

*

1.79 (1.01)

*

45.4%

*

45.8%

*

1.57
(0.37)
48.7%

7.5%

25.6%

*

14.4%

*

12.9%

SMW - General
population panel
sample

SMW - Targeted
panel sample

SMW - Longitudinal
Chicago sample
(CHLEW)

SMW - General
population
panel sample

SMW Targeted panel
sample

62.0%

57.9%

60.9%

28.9%

26.3%

24.8%

9.1%

15.8%

14.4%

51.35
(11.90)
31.2%

44.19
(12.27)
41.6%

*

49.06
(14.72)
26.7%

61.2%

63.4%

*

63.4%

*

83.0%

*

94.3%

*

Race/ethnicity
*

39.6%

*

40.0%
29.0%

93.5%

Relationship status

*

*

*
*
*
*
*

*
*
*

*
*
*

88.8%

*

58.6%

59.6%

53.2%

13.7%

17.0%

12.8%

5.6%

*

6.5%

1.18
(0.42)
31.0%

1.18
(0.43)
38.9%

7.9%

8.0%

*

11.9%

*

1.16
(0.37)
28.8%
6.0%

Indicates standard mean difference larger than |0.20|. SD = standard deviation. Reference groups: Employment = unemployed; Education = high school or less

ATOD use across these demographic groups. The second set of PS
weights used the expanded demographic covariates to address differ
ences in risk and protective factors related to socioeconomic status
(employment, education), relationship status, and parenting status. The
third set of PS weights used demographic covariates and ATOD-specific
risk factors that are known to vary by sexual identity, including early
onset of drinking, history of child abuse, and using substances to cope
with stress. For comparisons between SMW samples, the first three sets
of PS weights were calculated as described above, with a fourth set of PS
weights that included the SMW-specific protective factor (disclosure of
sexual identity) in addition to the full set of demographic characteristics
and ATOD risk factors. To be compatible with the PS weighted analyses,
we constructed covariate-adjusted logistic regression models that fol
lowed the same steps in the four sets of PS weights, progressively
including the expanded sets of covariates as adjustments in comparisons
of each pair of groups. We also report unadjusted logistic regression
results for each comparison. Testing these models provided an oppor
tunity to compare the more complex PSW results with results using the
most common regression approaches for addressing covariates that may
impact outcomes by sexual identity.
To achieve optimal balance of covariates (potential confounders)
across groups, we used generalized boosted models (GBM; McCaffrey
et al., 2013) implemented in the TWANG Stata package (Cefalu et al.,
2015) to estimate each set of PS weights. PS weighting via GBM models
uses iterative procedures based on regression/classification trees and
thereby avoids the more subjective model selection process common in
traditional parametric logistic regression analysis. Using GBM as an
automated data-adaptive algorithm has more desirable properties
(McCaffrey et al., 2004) than traditional PS model estimation based on
parametric linear logistic regression, especially with higher order

We also constructed variables assessing key risk factors for ATOD
use, including history of childhood physical or sexual abuse (vs. none),
early onset of drinking (first use by age 14 vs. later), and use of sub
stances to cope with stress. Use of substances to cope was based on a
subscale (average score across two questions) from the Brief COPE scale
(Carver, 1997), with a 4-category response option ranging from “not at
all” to “a lot.” We also assessed disclosure of sexual orientation to family
members in each of the three SMW samples, with four response options:
all, most, a few, or none.
2.3. Analysis
We conducted a series of logistic regression and propensity score (PS)
weighted analyses to compare outcomes across the four groups one by
one while progressively controlling for demographics and other cova
riates. For comparisons in the PS weighted analysis, we used the average
treatment effect among the treated (ATT), where a specific comparison
group was weighted to be statistically similar to the target group across
covariates that were potential confounders. Given our four samples, we
estimated ATT for six pairs of comparisons, with three for the
heterosexual-SMW comparisons (NAS vs. CHLEW; NAS vs. general
population panel sample; NAS vs. LGBTQ-specific panel sample) and
three for the SMW sample comparisons (CHLEW vs. LGBTQ-specific
panel sample; CHLEW vs. general population panel sample; and gen
eral population panel sample vs. LGBTQ-specific panel sample).
For each pair in the comparison, we progressively included the four
sets of covariates described above to estimate their corresponding PS
weights. For comparisons between heterosexual and SMW, the first set
of PS weights used only age and race/ethnicity demographic covariates
to account for oversampling strategies and to address key differences in
4
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interactions and polynomial terms involved and in terms of prediction
error (Friedman, 2001; Madigan and Ridgeway, 2004).
For our GBM models, we allowed up to cubic polynomials and threeway interactions (Elith et al., 2008) and we specified a maximum of 70,
000 iterations. For the stopping rule for optimal balancing, we used the
absolute standardized mean difference (also called standardized bias or
effect size) as our balance metric for each covariate at each iteration,
with the mean of those covariate balance metrics calculated across

covariates as the summary statistic for measuring model fit. Given a
sufficient number of iterations, the mean of the balance metrics will
generally reduce to an optimal number of iterations before increasing
again; thus, the final model can be determined by the iteration associ
ated with the lowest mean.
For some sets of PS weights estimated by GBM, covariates may not
completely balance. We considered a standardized mean difference with
absolute value greater than 0.2 after PS weighting as evidence of

Table 2
Estimated treatment effects of sexual minority identity status (versus heterosexual identity) on alcohol, tobacco and other drug outcomes.
Treatment effect when comparing the longitudinal Chicago sample with the heterosexual sample
Heavy (4 +) drinking
OR [95% CI], p-value

DSM-5 AUDa
OR [95% CI], p-value

Smoking
OR [95% CI], p-value

Frequent marijuana useb
OR [95% CI], p-value

Drug usec
OR [95% CI], p-value

3.21 [2.35–4.39], p <
.001
3.24 [2.32–4.53], p <
.001
2.54 [1.73–3.71], p <
.001
1.74 [1.14–2.65], p ¼ .01

5.05 [2.99–8.53], p <
.001
4.94 [2.89–8.45], p <
.001
4.11 [2.23–7.56], p <
.001
1.85 [0.94–3.64], p = .074

13.49 [6.43–28.33], p <
.001
12.47 [5.89–26.34], p <
.001
14.59 [6.44–33.02], p <
.001
7.82 [3.36–18.17], p < .001

3.63 [2.14–6.15], p < .001

4.06 [2.35–7.01], p <
.001
2.99 [1.54–5.81], p ¼
.001
1.68 [0.84–3.35], p = .144

10.64 [4.96–22.87], p <
.001
9.21 [4.17–20.33], p < .001

2.95 [1.68–5.17], p < .001

Weighted C

2.42 [1.74–3.38], p <
.001
1.71 [1.15–2.54], p ¼
.008
1.46 [0.93–2.28], p = .10

2.06 [1.46–2.92], p <
.001
1.92 [1.36–2.74], p <
.001
2.92 [1.88–4.52], p <
.001
1.75 [1.08–2.84], p ¼
.022
1.76 [1.21–2.56], p ¼
.003
1.98 [1.25–3.12], p ¼
.004
1.36 [0.8–2.32], p = .258

1.36 [0.67–2.75], p = .391

DR Weighted C

1.39 [0.88–2.21], p = .163

1.81 [0.74–4.42], p = .191

4.9 [2.16–11.13],
p < .001
5.61 [2.23–14.08], p < .001

Model
Unadjusted
regression
Adjusted A
Adjusted B
Adjusted C
PS Weighted A
Weighted B

Weighted C

1.9 [1.09–3.3],
p ¼ .024
Treatment effect when comparing the general population panel sample with the heterosexual sample
a
Heavy (4 +) drinking
DSM-5 AUD
Smoking
Frequent marijuana useb
OR [95% CI], p-value
OR [95% CI], p-value
OR [95% CI], p-value
OR [95% CI], p-value
5.16 [3.76–7.06], p <
5.38 [3.17–9.1],
2.59 [1.83–3.67], p <
16.58 [7.92–34.71], p <
.001
p < .001
.001
.001
2.96 [2.01–4.35], p <
3.81 [2.02–7.21], p <
3.14 [1.99–4.96], p <
17.57 [7.47–41.31], p <
.001
.001
.001
.001
2.92 [1.96–4.36], p <
3.64 [1.9–6.94],
3.16 [1.95–5.11], p <
17.18 [7.16–41.22], p <
.001
p < .001
.001
.001
1.68 [1.08–2.6], p ¼ .021
1.69 [0.82–3.46], p = .156
1.79 [1.05–3.03], p ¼
9.36 [3.76–23.24], p < .001
.031
3.37 [2.05–5.56], p <
4.61 [2.31–9.2],
2.53 [1.44–4.46], p ¼
15.13 [6.35–36.05], p <
.001
p < .001
.001
.001
3.1 [1.83–5.23], p < .001
4.12 [2.02–8.42], p <
2.09 [1.2–3.65],
13.82 [5.64–33.89], p <
.001
p ¼ .01
.001
2.3 [1.26–4.21], p ¼ .007
1.63 [0.74–3.58], p = .227
1.08 [0.57–2.04], p = .82
8.39 [3.23–21.78], p < .001

DR Weighted C

1.87 [0.98–3.55], p = .058

Model
Unadjusted
regression
Adjusted A
Adjusted B
Adjusted C
PS Weighted A
Weighted B

Model
Unadjusted
regression
Adjusted A
Adjusted B
Adjusted C
PS Weighted A
Weighted B
Weighted C
DR Weighted C

1.33 [0.57–3.11], p = .516

1.13 [0.57–2.25], p = .73

8.8 [2.88–26.9],
p < .001
Treatment effect when comparing the targeted sexual minority panel sample with the heterosexual sample
Heavy (4 +) drinking
DSM-5 AUDa
Smoking
Frequent marijuana useb
OR [95% CI], p-value
OR [95% CI], p-value
OR [95% CI], p-value
OR [95% CI], p-value
4.77 [3.44–6.63], p <
4.51 [2.61–7.8],
1.23 [0.83–1.83], p = .309
12.76 [6–27.14],
.001
p < .001
p < .001
3.24 [2.25–4.67], p <
2.89 [1.6–5.21],
1.14 [0.73–1.76], p = .567
8.98 [4.1–19.65],
.001
p < .001
p < .001
2.52 [1.65–3.85], p <
2.38 [1.19–4.74], p ¼
1.67 [0.98–2.87], p = .061
7.5 [3.16–17.81],
.001
.014
p < .001
1.65 [1.03–2.63], p ¼
1.09 [0.49–2.41], p = .837
1.19 [0.67–2.13], p = .55
3.82 [1.51–9.62],
.036
p ¼ .005
2.42 [1.59–3.68], p <
1.85 [0.96–3.58], p = .066
0.89 [0.52–1.52], p = .665
8.22 [3.54–19.07], p < .001
.001
2.83 [1.67–4.8], p < .001
2.06 [1.01–4.23], p ¼
1.02 [0.53–1.97], p = .961
13.33 [4.95–35.87], p <
.049
.001
2.25 [1.1–4.61], p ¼ .026
1 [0.41–2.4],
0.92 [0.41–2.06], p = .845
9.34 [2.41–36.16], p ¼
p = .992
.001
2.09 [1.08–4.05], p ¼
0.92 [0.36–2.3],
1.36 [0.57–3.23], p = .485
8.04 [2.27–28.45], p ¼
.029
p = .854
.001

3.41 [2–5.82],
p < .001
2.73 [1.48–5.03], p ¼
.001
1.78 [0.93–3.39], p = .082

1.77 [0.96–3.27], p = .066

1.29 [0.63–2.61], p = .487
Drug usec
OR [95% CI], p-value
7.06 [4.26–11.73], p <
.001
5.82 [3.15–10.77], p <
.001
5.64 [2.95–10.77], p <
.001
2.93 [1.46–5.86], p ¼
.002
6.36 [3.21–12.59], p <
.001
5.96 [2.93–12.12], p <
.001
3.6 [1.6–8.08],
p ¼ .002
3.21 [1.32–7.83],
p ¼ .01
Drug usec
OR [95% CI], p-value
6.74 [4.01–11.31], p <
.001
6.22 [3.57–10.83], p <
.001
4.98 [2.65–9.37], p < .001
3.15 [1.62–6.1],
p ¼ .001
7.16 [3.93–13.07], p <
.001
7.2 [3.73–13.89], p < .001
4.41 [2.08–9.38], p < .001
4.82 [2.11–10.99], p <
.001

Adjusted = adjusted multivariable logistic regression model; weighted = propensity score (PS) weighted model; covariates varied by model as follows: A = race/
ethnicity and age; B = race/ethnicity, age, minor children in household, employment, education and relationship status; C = race/ethnicity, age, minor children in
household, employment, education, relationship status, using substances to cope, childhood physical or sexual abuse, and early onset drinking. The double-robust (DR)
propensity score weighted models retained unbalanced covariates with standardized mean difference > |0.20| after propensity score weighted analyses; see Table 1 for
the covariates for each of the three comparisons with the heterosexual sample. a DSM-5 AUD = Alcohol use disorder as defined by the Diagnostic and Statistical Manual
of the American Psychiatric Association (5th edition); b frequent marijuana use was indicated by using marijuana at least weekly; c other drug use was indicated by
using any illicit drug other than marijuana at least once in the past year; OR = odds ratio; ORs with p-values < 0.05 are bolded.
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remaining imbalance. For the ATT effects using the third and fourth sets
of PS weights in group comparisons, covariates that remained unbal
anced after PS weighting were added to the model to estimate their ef
fects. This strategy of accounting for covariates that remain unbalanced
after PS weighting is called doubly robust estimation (Kang and Schafer,
2007; Neugebauer and van der Laan, 2005). Doubly robust estimation
has advantages over traditional PS weighting, including yielding
consistent estimates of the treatment effect if either the model for the
outcome or the propensity score model is incorrectly specified (Kang and
Schafer, 2007).
Balancing covariates helps elucidate whether and how outcomes
may differ between groups if they were exposed to similar risk and
protective factors. In addition, covariates that cannot be balanced by
simple PS weighting can provide insights about risk factors that may
deserve further consideration in future sampling designs and analysis
plans, as they are likely to contribute to differences in outcomes by
sexual identity.

.05) and elevated odds of being a smoker for SMW in CHLEW
(aOR=1.90, p < .05) that was maintained even in the double-robust PS
weighted models. Despite robust controls for confounders, the initial
elevated odds of frequent marijuana use and elevated odds of other drug
use persisted even in the double-robust PS weighted models (aORs
ranging from 3.2 to 8.8). The only exception was the odds of other drug
use among CHLEW SMW compared to heterosexual women. This com
parison was non-significant in the PS weighted model that accounted for
all demographics and ATOD-specific risk factors (OR=1.36, p = .39).
3.2. Comparisons of sexual minority samples
3.2.1. Covariate balance before and after PS weighting
Table 3 summarizes distributions of confounders across the SMW
samples before and after full PS weighting. Most confounders were
initially unbalanced when comparing the general population panel
sample of SMW with the CHLEW sample. However, after PS weighting,
the imbalance was reduced for all potential confounders except age,
employment status, and early onset of drinking. Fewer potential con
founders were initially unbalanced when comparing the targeted SMW
panel sample with the CHLEW sample, and all of the differences were
balanced by PS weighting.

3. Results
3.1. Comparison of SMW samples to heterosexual sample
3.1.1. Covariate balance before and after PS weighting
Table 1 shows distributions of confounders that were unbalanced
between the groups before and after applying the PS weights using the
maximal covariate set (e.g., in the comparisons of sexual identity bal
ance is reported after accounting for all demographic variables as well as
the ATOD-specific risk factors). As indicated by asterisks in the tables,
almost all of the possible confounders (except identification as Black/
African American) were initially unbalanced when comparing the SMW
samples with the heterosexual sample. After PS weighting, the imbal
ance was reduced for most confounders. However, across all three
comparisons, level of education remained unbalanced, and employment
status and relationship status (particularly the proportion separated/
divorced/widowed) also remained unbalanced for two of the three
comparisons. Further, the weighted general population panel sample of
SMW was significantly younger than the heterosexual comparison
sample, and the prevalence of childhood physical or sexual abuse also
remained higher than the corresponding prevalence among heterosex
ual women after PS weighting.

3.2.2. Assessment of sample differences in ATOD outcomes for SMW
The bivariate and adjusted multivariable regression models (Table 4)
showed only sporadic significant differences in the five ATOD outcomes
across the samples of SMW. The most persistent differences (those that
remained in the PS weighted models), were lower odds of alcohol use
disorder (OR=0.50, p = .005) and smoking (OR=0.53, p = .01) among
SMW from the targeted sexual minority panel sample than among the
CHLEW sample.
4. Discussion
The current study used PS weighting methods to examine differences
in ATOD use among sexual minority and heterosexual women under
hypothetical conditions in which three samples of SMW and their het
erosexual counterparts have similar risk and protective factors. Almost
all possible confounders were initially unbalanced when comparing the
SMW samples with the heterosexual sample. After PS weighting the
imbalance was substantially reduced, but not eliminated, highlighting
key covariates that merit attention in future studies of ATOD among
SMW.
In double-robust PS weighted models that accounted for unbalanced
covariates, all three SMW samples showed consistently higher odds of
drug use than heterosexual women, with odds ratios ranging from 5.6 to
8.8 to times greater for frequent marijuana use and 4.8–3.2 greater for
other drug use. Compared with the heterosexual sample, one SMW
sample showed higher odds of heavy drinking (the targeted panel
sample) and one (CHLEW) showed higher odds of smoking. None of the
SMW samples showed higher odds of alcohol use disorder in the doublerobust PS weighted models. These findings suggest that even when using
rigorous analytic methods to account for differences in demographics
and key risk factors (e.g., childhood abuse, early drinking onset) for
ATOD use and problems, SMW are significantly more likely than het
erosexual women to engage in frequent marijuana and other drug use.
These findings highlight the importance of ATOD screening by providers
in healthcare and social service agencies serving women and LGBTQ
communities to identify SMW who may be in need of brief intervention
or referral to more intensive treatment services (Smith et al., 2010).

3.1.2. Associations of sexual minority status with ATOD outcomes
Tests of the bivariate regression models indicated significantly
higher odds among SMW for each of the five ATOD outcomes in all three
comparisons with heterosexual women (Table 2, Unadjusted). The only
exception was tobacco use among SMW from the targeted panel sample,
which did not significantly differ from heterosexual women in any
models.
Fully adjusted multivariable regression models (Adjusted C) showed
that many significant associations of SMW identity with the ATOD
outcomes remained after including demographics and other con
founders. The associations indicated increased odds of heavy drinking
(adjusted odds ratios [aORs] ranging from 1.65 for the targeted panel
sample to 1.74 for the CHLEW sample in comparison with the hetero
sexual sample; all p < .05), being a smoker (aOR=1.75 for CHLEW and
1.79 for the general population SMW panel sample; both p < .05),
frequent marijuana use (aORs ranging from 3.82 for the targeted panel
sample to 9.36 for the general population panel sample; all p < .005),
and use of other drugs in the past year (aOR=2.93 for the general
population panel sample and 3.15 for the targeted panel sample; both p
< .05) for SMW compared to heterosexual women.
Some, but not all, differences in the ATOD outcomes were reduced to
non-significance in the PS weighted models (Weighted C) and doublerobust PS weighted models (DR Weighted C), which showed similar
findings. Compared to the heterosexual sample, we found elevated odds
of heavy drinking for SMW in the targeted panel sample (aOR=2.09, p <

4.1. Differences between SMW and heterosexual women
Covariate distributions prior to weighting highlighted several de
mographic differences among the SMW samples relative to the hetero
sexual sample that had been identified in prior research, such as younger
6
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Table 3
Comparing web panel samples of sexual minority women with longitudinal Chicago study: Covariate balance before and after propensity score weighted analyses.

Race/ethnicity
Non-Hispanic White
Black/African American
Hispanic/Latinx
Age (mean, SD)
Minor children in home
Employed
College education
Relationship status
Married
Living with someone as couple
Separated, divorced or widowed
Single/never married
Substance use to cope (mean, SD)
Childhood physical or sexual abuse
Early onset drinking
Disclosure of sexual identity
Not out to anyone
Only disclosed to a few people
Disclosed to most people
Bisexual

Comparison group

Unweighted

After full PS weighting

SMW - CHLEW

SMW - General population
panel sample

SMW - Targeted panel
sample

SMW - General population
panel sample

SMW - Targeted panel
sample

48.1%
37.9%
14.1%
47.1 (12.51)
11.5%
76.0%
86.7%

39.6%
25.5%
35.0%
31.54 (10.20)
41.5%
74.3%
70.7%

40.0%
29.0%
31.0%
39.05 (13.52)
12.6%
81.0%
93.5%

51.4%
34.0%
14.6%
41.44 (10.19)
12.7%
88.7%
92.2%

49.3%
34.1%
16.6%
46.81 (12.80)
13.8%
80.2%
92.3%

30.4%
34.8%
4.6%

27.4%
46.6%
5.7%

1.455 (0.76)
45.3%
25.3%

1.793 (1.01)
45.8%
14.4%

*

2.3%
10.2%
13.6%
22.0%

17.9%
30.4%
16.5%
52.6%

*
*

*
*
*
*
*
*

*

*

*
*

29.0%
37.1%
2.3%

29.7%
38.9%
3.3%

32.4%
31.3%
3.8%

1.565 (0.37)
48.7%
12.9%

1.437 (0.74)
44.8%
7.2%

1.418 (0.66)
49.7%
19.6%

4.2%
19.4%
24.5%
24.8%

*

*
*

*
*
*

1.6%
9.7%
15.6%
25.3%

*

2.9%
10.2%
15.6%
14.5%

*

Indicates standard mean difference larger than |0.20|. SD = standard deviation. Reference groups: Employment = unemployed; Education = high school or less;
Relationship status = Single/never married; Disclosure = Has disclosed to all

average age, higher levels of education, lower rates of marriage, and
higher rates of being single and never married (Lunn et al., 2017). Also
as in prior studies, SMW were more likely than heterosexual women to
report childhood physical or sexual abuse and early onset drinking
(Hughes, McCabe et al., 2010; Wilsnack et al., 2008), and to endorse
substance use as a coping strategy (Talley et al., 2012). These risk factors
may be important intervention targets to reduce the burden of ATOD use
and associated problems among SMW. In particular, the high prevalence
of physical and/or sexual abuse early in life (45–49% across the SMW
samples) and greater use of substances to cope with stress may be
important foci for both prevention and treatment. Further, qualitative
research to understand why these risk factors are elevated for SMW and
how they manifest in ATOD use would be informative.

4.3. Study strengths and limitations
This study is unique in its inclusion of three distinct samples of SMW
and the use of rigorous double-robust PSW strategies to balance and
account for key confounders of the association between sexual identity
with and ATOD outcomes, ranging from any smoking to alcohol use
disorder. However, the PSW methods did not completely reduce dif
ferences in ATOD outcomes across sexual identity to non-significance for
all comparisons. This suggests other factors also influence SMW’s ATOD
use and these should be examined in future studies, particularly in
relation to frequent use of marijuana and other drugs. Further, there
may be other important behavioral health conditions associated with
ATOD use, such as depression and anxiety, as well as experiences of
gender- and sexual identity-based discrimination, that could help to
explain variability in the outcomes, but these were not available for all
four samples. Finally, in comparisons between samples of SMW, mea
sures of gender presentation and associated discrimination may also
may illustrate additional factors contributing to differences in ATOD
outcomes.
Future research might further explore differences by sexual identity
in ATOD outcomes using PSW or matching strategies to balance even
more confounders across groups. Some matching strategies, such as
coarse exact matching, require large control or comparison groups from
which to select respondents that best match the focal treatment group
(in our case, SMW). In some instances, it may be possible to use these
matching strategies, but in the absence of sufficient sample sizes of
comparison groups, PSW strategies provide an effective solution by
creating a comparison group that is as similar as possible to the focal
group. Another advantage is that PSW affords the benefit of being able to
accommodate more covariates and confounders than matching
strategies.

4.2. Differences among the SMW samples
In analyses adding SMW-specific resiliency factors to the set of
possible confounders, only a few outcomes differed among the three
SMW samples after full weighting, and there were only sporadic dif
ferences in outcomes across these samples. This finding is encouraging
in relation to the potential utility of different types of samples when
investigating substance use outcomes among SMW. Nonprobability
samples, such as the CHLEW sample and the web panel samples, allow
for recruitment of large numbers of SMW and greater coverage of SMWspecific risk and resiliency factors (Institute of Medicine, 2011; Meyer
and Wilson, 2009). Although the panel samples differed from the lon
gitudinal CHLEW sample on a few demographics such as age (the
CHLEW sample was older), inclusion of SMW in general population
samples along with women identified through LGBTQ-specific web
panels or other LGBTQ community resources helped to increase the di
versity of demographics and life-experiences, potentially making find
ings more generalizable. Our findings suggest that panel samples have
promise in addressing some of the limitations of other sampling methods
such as RDS or probability sampling that are difficult to achieve in a
cost-effective manner with SMW (Martin et al., 2015; Michaels et al.,
2019; Middleton et al., 2022).

4.4. Conclusions
Disparities in substance use, most notably marijuana and other drug
use, were evident among SMW relative to heterosexual women across
samples recruited using different sampling strategies, although the size
of the difference varied by sample. These findings provide some reas
surance about the validity of large nonprobability samples, which
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Table 4
Estimated treatment effects of web panel status (vs. longitudinal study) on alcohol, tobacco and other drug outcomes.
Treatment effect when comparing the general population panel sample of sexual minority women with
the sexual minority women in the longitudinal Chicago sample
Heavy (4 +) drinking
Model
Unadjusted regression
Adjusted A
Adjusted B
Adjusted C
Adjusted D
PS Weighted A
Weighted B
Weighted C
Weighted D
DR Weighted D

Model
Unadjusted regression
Adjusted A
Adjusted B
Adjusted C
Adjusted D
PS Weighted A
Weighted B
Weighted C
Weighted D
DR Weighted Dd

DSM-5 AUDa

Smoking

OR [95% CI],
OR [95% CI],
OR [95% CI],
p-value
p-value
p-value
1.6 [1.21–2.13],
1.07 [0.74–1.53],
1.25 [0.91–1.72],
p ¼ .001
p = .733
p = .162
0.88 [0.62–1.26],
0.68 [0.43–1.05],
1.12 [0.76–1.65],
p = .491
p = .083
p = .579
0.94 [0.65–1.37],
0.68 [0.43–1.09],
0.99 [0.65–1.5],
p = .76
p = .108
p = .958
0.82 [0.55–1.23],
0.5 [0.3–0.85],
0.93 [0.59–1.47],
p = .337
p ¼ .01
p = .766
0.88 [0.57–1.34],
0.5 [0.29–0.85],
1.01 [0.63–1.62],
p = .542
p ¼ .011
p = .965
1.46 [0.96–2.21],
1.23 [0.73–2.07],
1.3 [0.83–2.05],
p = .074
p = .437
p = .251
1.23 [0.74–2.03],
1.15 [0.63–2.08],
1.17 [0.69–1.99],
p = .424
p = .655
p = .552
1.03 [0.66–1.61],
0.9 [0.51–1.59],
1.09 [0.67–1.78],
p = .89
p = .717
p = .728
1.32 [0.73–2.38],
0.98 [0.51–1.89],
0.98 [0.52–1.82],
p = .35
p = .95
p = .939
0.94 [0.52–1.69],
0.85 [0.43–1.72],
1.01 [0.54–1.88],
p = .84
p = .659
p = .974
Treatment effect when comparing the targeted sexual minority panel sample with
the sexual minority women in the longitudinal Chicago sample
Heavy (4 +) drinking
DSM-5 AUDa
Smoking
OR [95% CI],
OR [95% CI],
OR [95% CI],
p-value
p-value
p-value
1.49 [1.1–2],
0.89 [0.6–1.32],
0.6 [0.41–0.86],
p ¼ .009
p = .574
p ¼ .006
0.98 [0.7–1.37],
0.58 [0.38–0.9],
0.48 [0.32–0.72],
p = .91
p ¼ .015
p < .001
1.01 [0.72–1.42],
0.6 [0.38–0.94],
0.52 [0.34–0.79],
p = .958
p ¼ .024
p ¼ .002
1.02 [0.71–1.48],
0.59 [0.35–0.98],
0.54 [0.35–0.85],
p = .913
p ¼ .041
p ¼ .007
0.95 [0.65–1.4],
0.55 [0.32–0.93],
0.55 [0.35–0.86],
p = .809
p ¼ .026
p ¼ .009
0.97 [0.64–1.45],
0.45 [0.27–0.75],
0.47 [0.29–0.77],
p = .87
p ¼ .002
p ¼ .003
1.00 [0.7–1.41],
0.51 [0.32–0.81],
0.54 [0.34–0.85],
p = .977
p ¼ .005
p ¼ .008
0.97 [0.68–1.39],
0.53 [0.32–0.86],
0.57 [0.36–0.9],
p = .877
p ¼ .01
p ¼ .015
0.94 [0.65–1.35],
0.5 [0.31–0.81],
0.53 [0.33–0.86],
p = .726
p ¼ .005
p ¼ .01
–
–
–

Frequent marijuana useb

Drug usec

OR [95% CI],
p-value
1.23 [0.87–1.73],
p = .241
0.85 [0.55–1.3],
p = .454
0.77 [0.49–1.21],
p = .261
0.69 [0.43–1.12],
p = .134
0.69 [0.42–1.14],
p = .151
1.24 [0.76–2.02],
p = .38
1.02 [0.56–1.84],
p = .95
0.98 [0.58–1.66],
p = .936
0.83 [0.46–1.5],
p = .53
0.77 [0.41–1.43],
p = .401

OR [95% CI],
p-value
1.95 [1.35–2.8],
p < .001
1.2 [0.77–1.87],
p = .408
1.27 [0.8–2.02],
p = .317
1.09 [0.67–1.79],
p = .718
0.96 [0.57–1.6],
p = .872
1.68 [1.01–2.77],
p ¼ .045
1.89 [1.03–3.47],
p ¼ .039
1.54 [0.87–2.71],
p = .134
1.22 [0.62–2.41],
p = .568
1.05 [0.52–2.14],
p = .889

Frequent marijuana useb
OR [95% CI],
p-value
0.95 [0.65–1.38],
p = .769
0.66 [0.43–1],
p = .048
0.66 [0.43–1.01],
p = .057
0.65 [0.41–1.03],
p = .067
0.66 [0.41–1.05],
p = .079
0.69 [0.43–1.11],
p = .126
0.79 [0.49–1.25],
p = .31
0.71 [0.44–1.15],
p = .166
0.87 [0.52–1.44],
p = .587
–

Drug usec
OR [95% CI],
p-value
1.86 [1.27–2.72],
p ¼ .001
1.54 [1.03–2.32],
p ¼ .036
1.6 [1.06–2.42],
p ¼ .026
1.59 [1.03–2.44],
p ¼ .037
1.56 [1–2.42],
p ¼ .049
1.4 [0.85–2.32],
p = .188
1.57 [1–2.46],
p ¼ .048
1.35 [0.86–2.12],
p = .196
1.42 [0.89–2.25],
p = .14
–

Adjusted = adjusted multivariable logistic regression model; weighted = propensity score weighted model; covariates varied by model as follows: A = race/ethnicity
and age; B = race/ethnicity, age, minor children in household, employment, education and relationship status; C = race/ethnicity, age, minor children in household,
employment, education, relationship status, using substances to cope, childhood physical or sexual abuse, and early onset drinking; D = race/ethnicity, age, minor
children in household, employment, education, relationship status, using substances to cope, childhood physical or sexual abuse, early onset drinking, identity
disclosure status and sexual identity. The double-robust weighted models retained unbalanced covariates with standardized mean difference > |0.20| after propensity
score weighted analyses; see Table 2 for the covariates for each of the three comparisons with the longitudinal Chicago sample. a DSM-5 AUD = Alcohol use disorder as
defined by the Diagnostic and Statistical Manual of the American Psychiatric Association (5th edition); b frequent marijuana use was indicated by using marijuana at
least weekly; c other drug use was indicated by using any illicit drug other than marijuana at least once in the past year; d No covariates remained unbalanced for this
sample comparison, so the double-robust PS weighted model D is the same as the fully-weighted model D. OR = odds ratio; ORs with p-values < 0.05 are bolded.

remain an important tool in ATOD research with SMW. The use of
rigorous methods to account for differences in demographics and key
risk factors for ATOD use and problems, including history of childhood
physical or sexual abuse, early onset of drinking, and using substances to
cope with stress, reduced disparities across seven of 15 comparisons
between SMW and heterosexual women. These findings suggest that
some factors, such as use of substances to cope with stress, may be
particularly salient to interventions with SMW.
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